Why is Torrent Pharma falling/rising?

As of 02-Jul, Torrent Pharmaceuticals Ltd. is currently priced at Rs 3,351.20, reflecting a decline of Rs 62.2 or 1.82%. The stock has underperformed its sector by 1.9% today and has experienced a trend reversal after three consecutive days of gains, touching an intraday low of Rs 3,335, which is a decrease of 2.3%. Despite this decline, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend over a longer period. Over the past week, the stock has shown a return of 3.63%, and over the past month, it has increased by 6.88%. The company has demonstrated strong financial performance, with a high return on capital employed (ROCE) of 22.33% and a low debt to EBITDA ratio of 1.26 times, which supports its ability to service debt effectively. Furthermore, it has reported positive results for the last seven consecutive quarters, contributing to its consistent returns over the past three years.
In the broader market context, Torrent Pharmaceuticals has outperformed the benchmark Sensex over the past week and month, with returns of 3.63% and 6.88%, respectively, compared to the Sensex's 0.79% and 2.50%. However, the year-to-date performance shows a slight decline of 0.13% against the Sensex's gain of 6.75%, indicating a lag in the stock's performance relative to the broader market. The stock's liquidity remains strong, with a delivery volume increase of 79.03% against the 5-day average, suggesting rising investor participation. Despite the current price drop, the high institutional holdings at 24.66% reflect confidence from more sophisticated investors, which may provide a stabilizing effect on the stock moving forward.